SCHEMBL4957206

SCHEMBL4957206

O=C(NC1C(O)OC(CO)C(O)C1O)C(O)C(O)C(O)C(O)CO

nearest known ligand 0.47

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 3/20 0.47
▸ KDM4E B2RXH2 1/20 0.47
▸ CYP2D6 P10635 1/20 0.47
▸ CYP2C19 P33261 1/20 0.47
▸ HK2 P52789 5/20 0.44
▸ HK1 P19367 4/20 0.44
▸ MAPK1 P28482 1/20 0.41
▸ PDE4A P27815 1/20 0.40
▸ ALDH1A1 P00352 1/20 0.36
▸ THRB P10828 1/20 0.36
▸ CA12 O43570 1/20 0.36
▸ CA1 P00915 1/20 0.36
▸ CA2 P00918 1/20 0.36
▸ CA9 Q16790 1/20 0.36
▸ PYGB P11216 4/20 0.35
▸ GAA P10253 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4954637 1.00 LMNA (0.47) LMNAKDM4ECYP2D6CYP2C19HK2
N-Acetylglucosamine SCHEMBL29263425 0.85 MAPK1 (0.56) LMNAKDM4ECYP2D6CYP2C19HK2
N-Acetylglucosamine SCHEMBL7745223 0.82 MAPK1 (0.56) LMNAKDM4ECYP2D6CYP2C19HK2
SCHEMBL8770830 0.82 PYGB (0.51) CA12CA1CA2CA9PYGB
N-Acetylglucosamine SCHEMBL29144670 0.80 MAPK1 (0.47) LMNAKDM4ECYP2D6CYP2C19HK2
N-Acetylglucosamine SCHEMBL27711409 0.79 MAPK1 (0.50) LMNAKDM4ECYP2D6CYP2C19HK2
SCHEMBL29852070 0.79 LMNA (0.56) LMNAKDM4ECYP2D6CYP2C19HK2
SCHEMBL4955152 0.79 LMNA (0.56) LMNAKDM4ECYP2D6CYP2C19HK2
SCHEMBL4955133 0.79 LMNA (0.56) LMNAKDM4ECYP2D6CYP2C19HK2
N-Acetylglucosamine SCHEMBL27889883 0.78 MAPK1 (0.52) LMNAKDM4ECYP2D6CYP2C19HK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012054528-A2 CHEMOSENSORY RECEPTOR LIGAND-BASED THERAPIES ELCELYX THERAPEUTICS, INC. (US) 2012-04-26 — — WO disclosed
Send feedback